Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2024-04, Vol.15, p.1414812-1414812
Main Authors: Barisa, Marta, Abate-Daga, Daniel, Fisher, Jonathan
Format: Article
Language:English
Subjects:
Animals
BiTe
CAR-T
checkpoint blockade (ICB) therapy
Combined Modality Therapy
Genetic Engineering
Humans
Immunology
immunotherapy
Immunotherapy - methods
Neoplasms - immunology
Neoplasms - therapy
oncology
Receptors, Antigen, T-Cell, gamma-delta - genetics
Receptors, Antigen, T-Cell, gamma-delta - immunology
Receptors, Antigen, T-Cell, gamma-delta - metabolism
γδT cell
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c420t-c98219dea68dcf333a12af7a64b4290888432ad30a6d30715df3be7b325b7863
container_end_page 1414812
container_issue
container_start_page 1414812
container_title Frontiers in immunology
container_volume 15
creator Barisa, Marta
Abate-Daga, Daniel
Fisher, Jonathan
description
doi_str_mv 10.3389/fimmu.2024.1414812
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5c9f12c87ae34c41b0c0087b806f885e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_5c9f12c87ae34c41b0c0087b806f885e</doaj_id><sourcerecordid>3050936900</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-c98219dea68dcf333a12af7a64b4290888432ad30a6d30715df3be7b325b7863</originalsourceid><addsrcrecordid>eNpVUctu1DAUtRCIVkN_gAXykk0Gv-I4bBCqSlupUjeztxznOnWV2KntIMFvwXf0m8h0hqr1wr66Pvfco3MQ-kjJlnPVfnF-mpYtI0xsqaBCUfYGnVIpRcUZE29f1CfoLOd7sh7Rcs7r9-iEK9kqVYtT9HDR-xKTN-NXfDsXP_nf0OMBAlQQBh8Akg8DNqHHNk6dD6b4GHC5g2RmDxmXiLsYc8GPfx7_7rCFccR7aSEeMLAUb_EMycU0mWDhA3rnzJjh7Phu0O7Hxe78qrq5vbw-_35TWcFIqWyrGG17MFL11q26DWXGNUaKTrCWKKUEZ6bnxMj1amjdO95B03FWd42SfIOuD7R9NPd6Tn4y6ZeOxuunRkyDNmmVNoKubesos6oxwIUVtCOWENV0iki3ugQr17cD17x0E_QWQklmfEX6-if4Oz3En5pSIjlfbd-gz0eGFB8WyEVPPu-9MgHikjUnNWm5bAlZoewAtSnmnMA976FE76PXT9HrffT6GP069OmlwueR_0Hzfx2crxs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3050936900</pqid></control><display><type>article</type><title>Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance</title><source>PubMed (Medline)</source><creator>Barisa, Marta ; Abate-Daga, Daniel ; Fisher, Jonathan</creator><creatorcontrib>Barisa, Marta ; Abate-Daga, Daniel ; Fisher, Jonathan</creatorcontrib><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2024.1414812</identifier><identifier>PMID: 38698854</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Animals ; BiTe ; CAR-T ; checkpoint blockade (ICB) therapy ; Combined Modality Therapy ; Genetic Engineering ; Humans ; Immunology ; immunotherapy ; Immunotherapy - methods ; Neoplasms - immunology ; Neoplasms - therapy ; oncology ; Receptors, Antigen, T-Cell, gamma-delta - genetics ; Receptors, Antigen, T-Cell, gamma-delta - immunology ; Receptors, Antigen, T-Cell, gamma-delta - metabolism ; γδT cell</subject><ispartof>Frontiers in immunology, 2024-04, Vol.15, p.1414812-1414812</ispartof><rights>Copyright © 2024 Barisa, Abate-Daga and Fisher 2024 Barisa, Abate-Daga and Fisher</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c420t-c98219dea68dcf333a12af7a64b4290888432ad30a6d30715df3be7b325b7863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11063349/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11063349/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38698854$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barisa, Marta</creatorcontrib><creatorcontrib>Abate-Daga, Daniel</creatorcontrib><creatorcontrib>Fisher, Jonathan</creatorcontrib><title>Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><subject>Animals</subject><subject>BiTe</subject><subject>CAR-T</subject><subject>checkpoint blockade (ICB) therapy</subject><subject>Combined Modality Therapy</subject><subject>Genetic Engineering</subject><subject>Humans</subject><subject>Immunology</subject><subject>immunotherapy</subject><subject>Immunotherapy - methods</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - therapy</subject><subject>oncology</subject><subject>Receptors, Antigen, T-Cell, gamma-delta - genetics</subject><subject>Receptors, Antigen, T-Cell, gamma-delta - immunology</subject><subject>Receptors, Antigen, T-Cell, gamma-delta - metabolism</subject><subject>γδT cell</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVUctu1DAUtRCIVkN_gAXykk0Gv-I4bBCqSlupUjeztxznOnWV2KntIMFvwXf0m8h0hqr1wr66Pvfco3MQ-kjJlnPVfnF-mpYtI0xsqaBCUfYGnVIpRcUZE29f1CfoLOd7sh7Rcs7r9-iEK9kqVYtT9HDR-xKTN-NXfDsXP_nf0OMBAlQQBh8Akg8DNqHHNk6dD6b4GHC5g2RmDxmXiLsYc8GPfx7_7rCFccR7aSEeMLAUb_EMycU0mWDhA3rnzJjh7Phu0O7Hxe78qrq5vbw-_35TWcFIqWyrGG17MFL11q26DWXGNUaKTrCWKKUEZ6bnxMj1amjdO95B03FWd42SfIOuD7R9NPd6Tn4y6ZeOxuunRkyDNmmVNoKubesos6oxwIUVtCOWENV0iki3ugQr17cD17x0E_QWQklmfEX6-if4Oz3En5pSIjlfbd-gz0eGFB8WyEVPPu-9MgHikjUnNWm5bAlZoewAtSnmnMA976FE76PXT9HrffT6GP069OmlwueR_0Hzfx2crxs</recordid><startdate>20240418</startdate><enddate>20240418</enddate><creator>Barisa, Marta</creator><creator>Abate-Daga, Daniel</creator><creator>Fisher, Jonathan</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240418</creationdate><title>Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance</title><author>Barisa, Marta ; Abate-Daga, Daniel ; Fisher, Jonathan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-c98219dea68dcf333a12af7a64b4290888432ad30a6d30715df3be7b325b7863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>BiTe</topic><topic>CAR-T</topic><topic>checkpoint blockade (ICB) therapy</topic><topic>Combined Modality Therapy</topic><topic>Genetic Engineering</topic><topic>Humans</topic><topic>Immunology</topic><topic>immunotherapy</topic><topic>Immunotherapy - methods</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - therapy</topic><topic>oncology</topic><topic>Receptors, Antigen, T-Cell, gamma-delta - genetics</topic><topic>Receptors, Antigen, T-Cell, gamma-delta - immunology</topic><topic>Receptors, Antigen, T-Cell, gamma-delta - metabolism</topic><topic>γδT cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barisa, Marta</creatorcontrib><creatorcontrib>Abate-Daga, Daniel</creatorcontrib><creatorcontrib>Fisher, Jonathan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barisa, Marta</au><au>Abate-Daga, Daniel</au><au>Fisher, Jonathan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2024-04-18</date><risdate>2024</risdate><volume>15</volume><spage>1414812</spage><epage>1414812</epage><pages>1414812-1414812</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>38698854</pmid><doi>10.3389/fimmu.2024.1414812</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2024-04, Vol.15, p.1414812-1414812
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_5c9f12c87ae34c41b0c0087b806f885e
source PubMed (Medline)
subjects Animals
BiTe
CAR-T
checkpoint blockade (ICB) therapy
Combined Modality Therapy
Genetic Engineering
Humans
Immunology
immunotherapy
Immunotherapy - methods
Neoplasms - immunology
Neoplasms - therapy
oncology
Receptors, Antigen, T-Cell, gamma-delta - genetics
Receptors, Antigen, T-Cell, gamma-delta - immunology
Receptors, Antigen, T-Cell, gamma-delta - metabolism
γδT cell
title Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A10%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial:%20Optimized%20gene-engineering%20and%20combination%20therapies%20to%20boost%20%CE%B3%CE%B4T%20cell%20immunotherapeutic%20performance&rft.jtitle=Frontiers%20in%20immunology&rft.au=Barisa,%20Marta&rft.date=2024-04-18&rft.volume=15&rft.spage=1414812&rft.epage=1414812&rft.pages=1414812-1414812&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2024.1414812&rft_dat=%3Cproquest_doaj_%3E3050936900%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c420t-c98219dea68dcf333a12af7a64b4290888432ad30a6d30715df3be7b325b7863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3050936900&rft_id=info:pmid/38698854&rfr_iscdi=true